Gaurav Maini
Stock Analyst at LifeSci Capital
(2.87)
# 2,672
Out of 4,423 analysts
28
Total ratings
50%
Success rate
8.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Maintained: Buy | $60 | $37.30 | +60.86% | 9 | Jun 18, 2026 | |
| TECX Tectonic Therapeutic | Rated: Buy | $88 | $30.03 | +193.04% | 7 | Jun 10, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $27 | $12.00 | +125.00% | 5 | May 16, 2026 | |
| LQDA Liquidia | Maintained: Buy | $71 | $71.07 | -0.10% | 3 | May 16, 2026 | |
| IKT Inhibikase Therapeutics | Maintained: Buy | $5 | $1.83 | +173.22% | 4 | May 16, 2026 |
Sionna Therapeutics
Jun 18, 2026
Maintained: Buy
Price Target: $60
Current: $37.30
Upside: +60.86%
Tectonic Therapeutic
Jun 10, 2026
Rated: Buy
Price Target: $88
Current: $30.03
Upside: +193.04%
Tenax Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $27
Current: $12.00
Upside: +125.00%
Liquidia
May 16, 2026
Maintained: Buy
Price Target: $71
Current: $71.07
Upside: -0.10%
Inhibikase Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $1.83
Upside: +173.22%